Inari Medical, Inc.
NARI
Classifica tra le azioni
#3691
Inari Medical, Inc. is a medical technology firm focused on creating,... Inari Medical, Inc. is a medical technology firm focused on creating, producing, promoting, and distributing devices for the minimally invasive management of venous conditions within the United States. Their product portfolio includes ClotTriever, a mechanical thrombectomy solution designed to extract significant clots from major blood vessels, specifically targeting deep vein thrombosis. Another key offering is FlowTriever, a substantial catheter-based aspiration and mechanical thrombectomy system, which addresses pulmonary embolism. The company also provides FlowSaver; FlowStasis, a large-bore suture retention device to manage venous access points; and FlowTriever 2, an enhanced version with a new disk design for efficiently capturing wall-adherent clots and reducing procedure time. Founded in 2011, the company was initially known as Inceptus Newco1 Inc. before rebranding as Inari Medical, Inc. in September 2013. Its corporate headquarters are located in Irvine, California.
Prezzo delle azioni
$79.97
Ultima sincronizzazione: 2025-02-19
Capitalizzazione di mercato
$4.57B
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Inari Medical, Inc. (NARI)
Categoria
Healthcare
Ricavi di Inari Medical, Inc. (NARI)
Ricavi nel Sep 2024 TTM: $574.50M
Secondo gli ultimi rapporti finanziari di Inari Medical, Inc., i ricavi attuali dell'azienda (TTM) sono pari a $574.50M. Nel 2022, l'azienda ha registrato ricavi di $383.47M un aumento rispetto a i ricavi dell'anno 2021, che erano pari a $276.98M. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Inari Medical, Inc. da 2018 a 2026
Ricavi alla fine di ogni anno
| Anno | Ricavi | Cambia |
|---|---|---|
| 2026 (TTM) | $574.50M | 16.38% |
| 2023 | $493.63M | 28.73% |
| 2022 | $383.47M | 38.45% |
| 2021 | $276.98M | 98.31% |
| 2020 | $139.67M | 173.17% |
| 2019 | $51.13M | 648.70% |
| 2018 | $6.83M | 0.00% |
Ricavi di aziende simili o concorrenti
| Azienda | Ricavi | Differenza nei ricavi | Il paese |
|---|---|---|---|
| $46.59B | 8,008.82% |
US
|
|
| $35.48B | 6,076.52% |
IE
|
|
| $25.84B | 4,397.32% |
US
|
|
| $21.00B | 3,554.67% |
US
|
|
| - | - |
DE
|
